奈达铂治疗鼻咽癌的研究进展  

Research progress of nedaplatin in the treatment of nasopharyngeal carcinoma

作　　者：石宇[1] 王仁生[1] 

机构地区：[1]广西医科大学第一附属医院放疗科,南宁530007

出　　处：《国际肿瘤学杂志》2012年第9期680-682,共3页Journal of International Oncology

基　　金：广西卫生医疗重点科研课题（重2011074）

摘　　要：鼻咽癌的诱导化疗和同期放化疗一直是临床研究的热点。以顺铂为代表的铂类药物在提高鼻咽癌治疗疗效的同时也带来了很大的不良反应，新型铂类奈达铂的出现在保证疗效的同时降低了化疗的不良反应。Inductive chemotherapy and concurrent chemoradiotherapy have been a focus on the clinical research in the treatment of nasopharyngeal carcinoma. Cisplatin, as a kind of representative platinum drug, can improve the curative effect, but it also brings a lot of side effects to nasopharyngeal carcinoma patients. The new kind of platinum drug-nedaplatin, can not only guarantee the curative effect but also reduce the side effects of chemotherapy.

关 键 词：鼻咽肿瘤 奈达铂 诱导化疗 同期放化疗 

分 类 号：R739.63[医药卫生—肿瘤]